Nuclear Medicine News and Research RSS Feed - Nuclear Medicine News and Research

Nuclear medicine is a branch or specialty of medicine and medical imaging that uses radioactive isotopes (radionuclides) and relies on the process of radioactive decay in the diagnosis and treatment of disease. In nuclear medicine procedures, radionuclides are combined with other chemical compounds or pharmaceuticals to form radiopharmaceuticals.
Cross-disciplinary concepts may lead to effective, personalised cancer treatments

Cross-disciplinary concepts may lead to effective, personalised cancer treatments

It is not only tumours and metastases that differ in each type of cancer and each individual sufferer but also receptors in cells. [More]
New JGU cyclotron to be employed for research into potential applications in medicine

New JGU cyclotron to be employed for research into potential applications in medicine

A new particle accelerator is further enhancing the research landscape at Johannes Gutenberg University Mainz. [More]
Next-generation advanced translational research preclinical imaging system unveiled by Bruker

Next-generation advanced translational research preclinical imaging system unveiled by Bruker

Bruker today unveils two new preclinical imaging systems at the World Molecular Imaging Congress 2016 in New York. The new systems are designed to deliver highest performance and improved convenience for routine imaging, and enable novel translational research into the causes, progression, as well as potential diagnosis and treatment of disease. [More]
New PET scan can detect prostate cancer earlier than MRIs and CT scans

New PET scan can detect prostate cancer earlier than MRIs and CT scans

Loyola Medicine is the first center in the Midwest to offer the first effective PET/CT scan for prostate cancer patients. [More]
Advances in nuclear medicine production: an interview with Jayne Senior

Advances in nuclear medicine production: an interview with Jayne Senior

In my view, one of the greatest changes in recent history that has come about in nuclear medicine production is Australia’s full adoption of Low-Enriched Uranium (LEU) technologies – in both the fuel and the target plates. [More]
New NCCN Imaging AUC released for eight new cancers

New NCCN Imaging AUC released for eight new cancers

The National Comprehensive Cancer Network, a Centers for Medicare & Medicaid Services-approved provider-led entity for imaging appropriate use criteria, continues to build its library of AUC and has published NCCN Imaging Appropriate Use Criteria for eight new cancer types. Launched in June 2016, NCCN Imaging AUC currently are available for 20 cancer types. [More]
Study demonstrates safety and effectiveness of new SLN radiotracer in breast cancer patients

Study demonstrates safety and effectiveness of new SLN radiotracer in breast cancer patients

Determining whether breast cancer has spread to sentinel lymph nodes (SLN) is key to prognosis and treatment, making SLN mapping critical. [More]
Background parenchymal enhancement of the breast not linked to increased risk of cancer

Background parenchymal enhancement of the breast not linked to increased risk of cancer

Women with a certain gene mutation are among the high-risk patients for breast cancer. With a magnetic resonance tomography (MRT) it is possible to detect tissue with measurable active blood supply which indicates an increased breast cancer risk. [More]
Sydney’s new nuclear medicine facility moves forward towards completion

Sydney’s new nuclear medicine facility moves forward towards completion

The international medical community is closely watching Sydney’s Sutherland Shire, as one of the world’s newest and most advanced nuclear medicine production facilities, moves forward towards completion. [More]
Researchers seek to develop novel antibody to treat glioblastoma

Researchers seek to develop novel antibody to treat glioblastoma

Scientists of Helmholtz Zentrum München and the Munich University Hospital are developing a novel antibody to treat brain tumors. [More]
New molecular breast imaging gives better image quality with reduced radiation dose

New molecular breast imaging gives better image quality with reduced radiation dose

Preliminary tests have demonstrated that a new device may enable existing breast cancer imagers to provide up to six times better contrast of tumors in the breast, while maintaining the same or better image quality and halving the radiation dose to patients. [More]
New, portable molecular imaging system combines optical imaging and scintigraphy

New, portable molecular imaging system combines optical imaging and scintigraphy

Bigger isn't always better, especially when it comes to a new and surprisingly portable molecular imaging system that combines optical imaging at the surface level and scintigraphy, which captures the physiological function of what lies beneath, announced developers at the 2016 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging. [More]
CT-derived SULps can improve accuracy of PET imaging in advanced cancer patients

CT-derived SULps can improve accuracy of PET imaging in advanced cancer patients

Cancer patients often experience significant fluctuations in weight and lean body mass (LBM). Neglecting to account for these changes can prevent clinicians from obtaining precise data from molecular imaging, but a new method of measuring LBM takes changes in individual body composition into account for better staging of disease and therapy monitoring, say researchers at the 2016 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging. [More]
FDG-PET imaging tracks ability of atezolizumab to bolster immunity against NSCLC

FDG-PET imaging tracks ability of atezolizumab to bolster immunity against NSCLC

Non-small cell lung cancers have a collective reputation for not responding very well to chemotherapy. Researchers at the 2016 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI) are presenting a means of evaluating an immunotherapy that fights off NSCLC by strengthening a patient's own immune system. [More]
Molecular imaging technique could help optimize radiotherapy dose to combat NETs

Molecular imaging technique could help optimize radiotherapy dose to combat NETs

Aggressive neuroendocrine cancer is something of a dark horse--a rare, elusive and persevering force linked to discouraging long-term survival rates. [More]
New imaging study links tau proteins to neurodegenerative pathology of Alzheimer's disease

New imaging study links tau proteins to neurodegenerative pathology of Alzheimer's disease

Alzheimer's is a devastating and incurable disease marked by beta-amyloid and tau protein aggregations in the brain, yet the direct relationship between these proteins and neurodegeneration has remained a mystery. [More]
Genetic blood test can help predict patient’s respone to neuroendocrine cancer therapy

Genetic blood test can help predict patient’s respone to neuroendocrine cancer therapy

Malignant neuroendocrine tumors (NETs) are relatively rare, notoriously difficult to treat, and associated with poor long-term survival. According to research presented at the 2016 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging, an investigative blood test could predict how patients will respond to peptide receptor radionuclide therapy (PRRT) before they commit to a course of treatment. [More]
PET imaging can help identify autoimmune inflammation in MS

PET imaging can help identify autoimmune inflammation in MS

The triggers of autoimmune inflammation in multiple sclerosis (MS) have eluded scientists for many years, but molecular imaging is bringing researchers closer to identifying them, while providing a means of evaluating next-generation therapies for MS, say researchers introducing a study at the 2016 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging. [More]
PET/CT imaging technique may provide way to break perpetual cycle of alcohol abuse

PET/CT imaging technique may provide way to break perpetual cycle of alcohol abuse

Alcoholism is a devastating disorder that too often leads to a perpetual cycle of abuse. An emerging molecular imaging technique may provide a way to break that cycle. [More]
Novel radioimmunotherapy may help cure colorectal cancer

Novel radioimmunotherapy may help cure colorectal cancer

An emerging cancer therapy has colorectal tumors surrounded. Presenters at the 2016 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging are unveiling a novel radioimmunotherapy that combines a cancer-seeking antibody with potent radionuclide agents, resulting in complete remission of colorectal cancer in mouse models. [More]
Advertisement
Advertisement